AI for Pharmaceutical
From molecule screening to regulatory filing — AI solutions that compress pharma timelines and improve success rates at every stage.
Get StartedWidelly delivers AI solutions engineered for the pharmaceutical industry — accelerating drug discovery, optimizing clinical trials, enhancing pharmacovigilance, and streamlining regulatory submissions. Our pharma AI models analyze molecular structures, predict drug-target interactions, and identify adverse event signals from real-world data.
We partner with pharmaceutical companies, biotech startups, and CROs to build ML pipelines that compress years from the drug development lifecycle while maintaining rigorous scientific and regulatory standards.
Key Capabilities
Molecule Discovery
Generative chemistry models that design novel molecules with target properties u2014 reducing screening from months to days.
Clinical Trial Optimization
AI for patient recruitment, site selection, protocol optimization, and real-time trial monitoring.
Pharmacovigilance AI
NLP systems that detect adverse event signals from literature, social media, and post-market surveillance data.
Regulatory Intelligence
AI-assisted regulatory submission preparation, gap analysis, and compliance tracking across global markets.
Real-World Evidence
ML pipelines that analyze EHR, claims, and registry data to generate real-world evidence for drug efficacy.
Real-World Use Cases
AI Drug Repurposing
Knowledge graph and ML system that identified 12 repurposing candidates for rare diseases from existing approved drugs.
Automated Pharmacovigilance
NLP pipeline processing 100K+ adverse event reports monthly with 85% signal detection accuracy.
Trial Site Optimization
Predictive model that improved clinical trial site selection, increasing enrollment rates by 40%.
AI-Powered vs Traditional Approach
| Aspect | Traditional | AI-Powered |
|---|---|---|
| Molecule Screening | Weeks of manual HTS | AI screens millions of molecules in hours |
| Trial Recruitment | Months of manual patient matching | AI matches patients in days u2014 50% faster enrollment |
| Adverse Event Detection | Manual literature review | NLP monitors millions of sources in real-time |
| Drug Design | Iterative synthesis and test cycles | Generative models design optimized candidates computationally |
Business Benefits
Faster Time-to-Market
AI compresses drug development timelines by 30-50% by accelerating discovery, trials, and submissions.
Higher Success Rates
Predictive models identify promising candidates earlier, reducing expensive late-stage failures.
Cost Reduction
AI-optimized trials, automated pharmacovigilance, and streamlined submissions reduce overall R&D costs.
Regulatory Confidence
AI-generated evidence packages and compliance tracking improve regulatory approval odds.
Implementation Process
Scientific Scoping
Define therapeutic area, data assets, and AI opportunity with domain scientists.
Data Engineering
Build molecular, clinical, and real-world data pipelines with quality controls.
Model Development
Train and validate predictive models with rigorous scientific methodology.
Production Deployment
Deploy models into research workflows with monitoring, retraining, and audit trails.
Technology Stack
Frequently Asked Questions
Ready to Build with AI?
Let's discuss how ai for pharmaceutical can transform your business operations.
Book AI Consultation